HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yue Gao Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2024Metabolic-Related Gene Prognostic Index for Predicting Prognosis, Immunotherapy Response, and Candidate Drugs in Ovarian Cancer.
1/2024Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.
1/2023Platelet RNA signature independently predicts ovarian cancer prognosis by deep learning neural network model.
1/2023Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study.
3/2021Clinical efficacy analysis of Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with Paclitaxel-Cisplatin Chemotherapy in patients with Advanced Ovarian Cancer.
1/2021Noninvasive evaluation of HABP1 expression with 99mTc-labeled small-interference RNA in ovarian cancer.
1/2020Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer.
11/2016Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yue Gao Research Topics

Disease

126Neoplasms (Cancer)
05/2024 - 01/2008
34Inflammation (Inflammations)
08/2024 - 05/2006
19Infections
01/2024 - 05/2003
17Breast Neoplasms (Breast Cancer)
10/2023 - 01/2015
15Neoplasm Metastasis (Metastasis)
04/2024 - 04/2015
14Mitochondrial Diseases (Mitochondrial Disease)
03/2024 - 10/2016
12Body Weight (Weight, Body)
11/2022 - 09/2014
11Hepatomegaly
05/2024 - 01/2019
11Hypoxia (Hypoxemia)
02/2024 - 05/2011
11Type 2 Diabetes Mellitus (MODY)
01/2023 - 01/2017
10Fibrosis (Cirrhosis)
05/2024 - 12/2016
10Wounds and Injuries (Trauma)
03/2024 - 09/2013
10Cardiotoxicity
01/2022 - 05/2013
10Glioma (Gliomas)
07/2021 - 04/2018
9Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 04/2015
9COVID-19
11/2023 - 07/2020
9Carcinogenesis
01/2023 - 12/2008
8Ovarian Neoplasms (Ovarian Cancer)
01/2024 - 11/2016
8Hepatocellular Carcinoma (Hepatoma)
12/2023 - 01/2017
8Melanoma (Melanoma, Malignant)
01/2023 - 10/2021
7Liver Diseases (Liver Disease)
05/2024 - 11/2019
7Alzheimer Disease (Alzheimer's Disease)
05/2024 - 10/2015
7Insulin Resistance
01/2023 - 01/2014
7Cholestasis
04/2022 - 10/2012
7Pancreatic Neoplasms (Pancreatic Cancer)
02/2021 - 06/2010
6Reperfusion Injury
02/2024 - 12/2009
6Obesity
01/2023 - 09/2013
6Necrosis
04/2022 - 05/2011
6Pancreatitis
06/2010 - 05/2003
5Parkinson Disease (Parkinson's Disease)
08/2024 - 01/2013
5Hypertrophy
05/2024 - 03/2014
5Liver Cirrhosis (Hepatic Cirrhosis)
05/2024 - 04/2015
5Diabetes Mellitus
03/2024 - 04/2018
5Neuroinflammatory Diseases
02/2024 - 01/2020
4Neurodegenerative Diseases (Neurodegenerative Disease)
08/2024 - 04/2016
4Pathologic Processes
05/2024 - 01/2015
4Prostatic Neoplasms (Prostate Cancer)
04/2024 - 08/2018
4Adenocarcinoma of Lung
02/2024 - 01/2016
4Hemorrhage
01/2024 - 09/2014
4Bites and Stings (Sting)
12/2023 - 01/2019
4Acute Promyelocytic Leukemia
12/2023 - 01/2017
4Asthma (Bronchial Asthma)
12/2023 - 05/2013
4Chronic Obstructive Pulmonary Disease (COPD)
12/2023 - 09/2019
4Intrahepatic Cholestasis
11/2023 - 10/2012
4Myocardial Infarction
11/2023 - 01/2017
4Autistic Disorder (Autism)
08/2023 - 10/2016

Drug/Important Bio-Agent (IBA)

44Proteins (Proteins, Gene)FDA Link
05/2024 - 05/2011
32Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2015
19Long Noncoding RNAIBA
07/2023 - 01/2016
17Dendrimers (Dendrons)IBA
08/2024 - 01/2021
17Messenger RNA (mRNA)IBA
03/2024 - 05/2007
15Small Interfering RNA (siRNA)IBA
05/2024 - 04/2015
13MicroRNAs (MicroRNA)IBA
06/2023 - 01/2015
12LipidsIBA
01/2023 - 10/2016
11Insulin (Novolin)FDA Link
11/2023 - 01/2014
11EnzymesIBA
11/2023 - 10/2013
11CytokinesIBA
01/2023 - 10/2017
9Pregnane X ReceptorIBA
11/2022 - 09/2014
8LipopolysaccharidesIBA
02/2024 - 10/2015
8RNA (Ribonucleic Acid)IBA
12/2023 - 01/2016
8Transcription Factors (Transcription Factor)IBA
01/2023 - 07/2016
8DNA (Deoxyribonucleic Acid)IBA
02/2021 - 06/2009
7GoldIBA
03/2023 - 01/2021
7InterleukinsIBA
01/2023 - 10/2017
7Triglycerides (Triacylglycerol)IBA
12/2022 - 01/2017
7Anti-Bacterial Agents (Antibiotics)IBA
07/2022 - 03/2013
6AconitineIBA
03/2024 - 01/2018
6AntigensIBA
01/2023 - 08/2015
6Competitive Endogenous RNAIBA
01/2022 - 07/2016
5AntioxidantsIBA
08/2024 - 01/2020
5CollagenIBA
05/2024 - 09/2013
5InterferonsIBA
04/2024 - 01/2019
5tanshinoneIBA
03/2024 - 01/2015
5SaponinsIBA
01/2024 - 01/2014
5Therapeutic UsesIBA
01/2024 - 06/2000
5Glucose (Dextrose)FDA LinkGeneric
11/2023 - 03/2016
5ginsenoside Rg1IBA
11/2023 - 12/2008
5CateninsIBA
10/2023 - 01/2019
5Indicators and Reagents (Reagents)IBA
04/2023 - 04/2018
5Immune Checkpoint InhibitorsIBA
03/2023 - 01/2020
5Blood Glucose (Blood Sugar)IBA
03/2023 - 01/2022
5Emodin (Archin)IBA
09/2022 - 01/2007
5Caspase 3 (Caspase-3)IBA
04/2022 - 02/2011
5artenimol (dihydroartemisinin)IBA
01/2018 - 06/2010
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2024 - 01/2022
4Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2024 - 01/2019
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
04/2024 - 01/2019
4NanogelsIBA
04/2024 - 06/2021
4CholesterolIBA
01/2024 - 01/2017
4Hemoglobins (Hemoglobin)IBA
12/2023 - 01/2017
4Deubiquitinating EnzymesIBA
10/2023 - 12/2019
4Ubiquitin-Specific ProteasesIBA
10/2023 - 02/2019
4bavachinIBA
09/2023 - 02/2018

Therapy/Procedure

62Therapeutics
08/2024 - 05/2003
22Immunotherapy
01/2024 - 07/2014
21Drug Therapy (Chemotherapy)
04/2024 - 06/2000
13Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2023 - 05/2013
7Radiotherapy
11/2023 - 01/2008
6Glycemic Control
06/2024 - 01/2019
4Oral Administration
01/2024 - 04/2016